This association has been consistently replicated in studies of uveal melanoma, breast, and ovarian cancers, where CHAC1 upregulation marks advanced disease states (Goebel et al., 2012; Liu, Y. et al., 2019). Here, CHAC1 is linked to ovarian carcinoma.